Ignite Creation Date:
2025-12-24 @ 3:51 PM
Ignite Modification Date:
2026-02-26 @ 12:41 AM
Study NCT ID:
NCT02970292
Status:
COMPLETED
Last Update Posted:
2020-06-17
First Post:
2016-11-18
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of Adjunctive Pimavanserin for the Treatment of Schizophrenia (ENHANCE-1)
Sponsor:
ACADIA Pharmaceuticals Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-10-26
Start Date Type:
ACTUAL
Primary Completion Date:
2019-05-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-06-25
Completion Date Type:
ACTUAL
First Submit Date:
2016-11-18
First Submit QC Date:
None
Study First Post Date:
2016-11-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-05-29
Results First Submit QC Date:
None
Results First Post Date:
2020-06-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-05-29
Last Update Post Date:
2020-06-17
Last Update Post Date Type:
ACTUAL